Doreen McBride

3.8k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Doreen McBride is a scholar working on Rheumatology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Doreen McBride has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 14 papers in Pathology and Forensic Medicine and 11 papers in Dermatology. Recurrent topics in Doreen McBride's work include Urticaria and Related Conditions (19 papers), Autoimmune Bullous Skin Diseases (14 papers) and Dermatology and Skin Diseases (9 papers). Doreen McBride is often cited by papers focused on Urticaria and Related Conditions (19 papers), Autoimmune Bullous Skin Diseases (14 papers) and Dermatology and Skin Diseases (9 papers). Doreen McBride collaborates with scholars based in Switzerland, Germany and United States. Doreen McBride's co-authors include Sigurveig Sigurdardottir, Thomas Keil, Laurian Zuidmeer, Roberto J. Rona, Charlotte Bernhard Madsen, Colin Summers, Davíð Gíslason, Jörgen Dahlström, Maria‐Magdalena Balp and Bernd Brüggenjürgen and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, British Journal of Dermatology and Allergy.

In The Last Decade

Doreen McBride

39 papers receiving 1.8k citations

Hit Papers

The prevalence of food allergy: A meta-analysis 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doreen McBride Switzerland 17 1.2k 536 468 384 305 39 1.9k
Bülent Enis Şekerel Türkiye 22 786 0.7× 202 0.4× 339 0.7× 373 1.0× 357 1.2× 92 1.4k
Nualanong Visitsunthorn Thailand 20 659 0.6× 129 0.2× 314 0.7× 378 1.0× 174 0.6× 115 1.3k
Luciana Kase Tanno France 28 2.1k 1.8× 469 0.9× 706 1.5× 811 2.1× 355 1.2× 112 3.0k
Stefania Arasi Italy 21 1.2k 1.0× 371 0.7× 290 0.6× 637 1.7× 111 0.4× 124 1.6k
Ingrid Terreehorst Netherlands 26 1.3k 1.1× 459 0.9× 634 1.4× 764 2.0× 505 1.7× 53 2.2k
Susan Leech United Kingdom 13 920 0.8× 129 0.2× 382 0.8× 567 1.5× 375 1.2× 24 1.5k
Ledit Ardusso Argentina 11 1.6k 1.3× 318 0.6× 481 1.0× 439 1.1× 228 0.7× 24 1.9k
Yvan St. Pierre Canada 24 886 0.7× 334 0.6× 308 0.7× 230 0.6× 192 0.6× 39 1.5k
Paul K. Keith Canada 23 1000 0.8× 300 0.6× 407 0.9× 1.0k 2.7× 127 0.4× 70 2.1k
Louis M. Mendelson United States 21 1.8k 1.5× 368 0.7× 722 1.5× 882 2.3× 206 0.7× 43 2.6k

Countries citing papers authored by Doreen McBride

Since Specialization
Citations

This map shows the geographic impact of Doreen McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen McBride more than expected).

Fields of papers citing papers by Doreen McBride

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen McBride. The network helps show where Doreen McBride may publish in the future.

Co-authorship network of co-authors of Doreen McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen McBride. A scholar is included among the top collaborators of Doreen McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen McBride. Doreen McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lacour, J.‐P., A. Khemis, F. Giordano‐Labadie, et al.. (2018). The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study). European Journal of Dermatology. 28(6). 795–802. 20 indexed citations
2.
Hollis, Kelly, Christina Proctor, Doreen McBride, et al.. (2018). Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study. American Journal of Clinical Dermatology. 19(2). 267–274. 50 indexed citations
3.
Stull, Donald E., Doreen McBride, Hao Tian, et al.. (2017). Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria. British Journal of Dermatology. 177(4). 1093–1101. 54 indexed citations
4.
Graham, James E., Doreen McBride, Donald E. Stull, et al.. (2016). Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria. PharmacoEconomics. 34(8). 815–827. 25 indexed citations
5.
McBride, Doreen, Mohamed Abuzakouk, M.M. Balp, et al.. (2016). Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries. Value in Health. 19(7). A573–A573. 1 indexed citations
6.
Stull, Donald E., et al.. (2016). Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling. Advances in Therapy. 33(2). 214–224. 15 indexed citations
7.
McBride, Doreen, M.M. Balp, Mohamed Abuzakouk, et al.. (2016). Assure-Csu: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity. Value in Health. 19(3). A124–A125. 1 indexed citations
8.
Hawe, Emma, et al.. (2016). EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria. PharmacoEconomics. 34(5). 521–527. 12 indexed citations
9.
Augustin, Matthias, et al.. (2016). Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany. Value in Health. 19(7). A568–A569. 2 indexed citations
10.
Sussman, Gordon, Susan Waserman, Paul K. Keith, et al.. (2015). Assure-Csu Canadian Results: Assessing Health Utility In Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d. Value in Health. 18(3). A175–A175. 1 indexed citations
11.
Graham, Christopher N., et al.. (2015). Estimation of Indirect (Work-Related Productivity) Costs Associated With Moderate-To-Severe Plaque Psoriasis In Germany. Value in Health. 18(7). A419–A419. 3 indexed citations
12.
Stull, Donald E., et al.. (2014). Patient preferences for health: the value patients place on differential severity of chronic spontaneous (Idiopathic) urticaria (CSU/CIU). Allergy. 2 indexed citations
16.
Brüggenjürgen, Bernd, et al.. (2010). Vorhofflimmern – epidemiologische, ökonomische und individuelle Krankheitsbelastung. DMW - Deutsche Medizinische Wochenschrift. 135(S 02). S21–S25. 6 indexed citations
17.
McBride, Doreen, Sarah Hardoon, Kate Walters, Susan Gilmour, & Rosalind Raine. (2010). Explaining variation in referral from primary to secondary care: cohort study. BMJ. 341(nov30 1). c6267–c6267. 71 indexed citations
18.
McBride, Doreen, et al.. (2008). The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany. Value in Health. 12(2). 293–301. 51 indexed citations
19.
Zuidmeer, Laurian, Roberto J. Rona, Davíð Gíslason, et al.. (2008). The prevalence of plant food allergies: A systematic review. Journal of Allergy and Clinical Immunology. 121(5). 1210–1218.e4. 336 indexed citations
20.
McBride, Doreen, Bernd Brüggenjürgen, Stephanie Roll, & Stefan N. Willich. (2007). Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. Journal of Thrombosis and Thrombolysis. 24(1). 65–72. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026